2,677
Views
14
CrossRef citations to date
0
Altmetric
Coronaviruses

SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong

, , , , , , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2116-2119 | Received 31 May 2022, Accepted 24 Jul 2022, Published online: 05 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kelvin Hei-Yeung Chiu, Cyril Chik-Yan Yip, Rosana Wing-Shan Poon, Kit-Hang Leung, Xin Li, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Vincent Chi-Chung Cheng & Kwok-Yung Yuen. (2023) Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C–C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections. Emerging Microbes & Infections 12:1.
Read now

Articles from other publishers (13)

Chun Zhou, Zhaopin Cai, Boxing Jin, Huisong Lin, Lingling Xu & Zhigang Jin. (2023) Saliva-based detection of SARS-CoV-2: a bibliometric analysis of global research. Molecular and Cellular Biochemistry 479:4, pages 761-777.
Crossref
Jihai Tang, Qinghua Xu, Chaoyin Zhu, Kun Xuan, Tao Li, Qingru Li, Xingya Pang, Zhenqiu Zha, Jinwei Li, Liyang Qiao, Haiyang Xu, Gang Wu, Yan Tian, Jun Han, Cuige Gao, Jiang Yi, Gui Qian, Xuxin Tian & Liangzhi Xie. (2024) Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial. Vaccines 12:2, pages 175.
Crossref
Bingyi Yang, Yun Lin, Weijia Xiong, Chang Liu, Huizhi Gao, Faith Ho, Jiayi Zhou, Ru Zhang, Jessica Y. Wong, Justin K. Cheung, Eric H.Y. Lau, Tim K. Tsang, Jingyi Xiao, Irene O.L. Wong, Mario Martín-Sánchez, Gabriel M. Leung, Benjamin J. Cowling & Peng Wu. (2024) Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study. The Lancet Regional Health - Western Pacific 43, pages 100969.
Crossref
Watheq Thabet Taher, Amen A. Bawazir, Talal A. Sallam & Khaled Alsurimi. (2023) Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study. BMC Infectious Diseases 23:1.
Crossref
Michael R. Mercier, Robert Koucheki, Johnathan R. Lex, Amir Khoshbin, Sam S. Park, Timothy R. Daniels & Mansur M. Halai. (2023) The association between preoperative COVID-19-positivity and acute postoperative complication risk among patients undergoing orthopedic surgery. Bone & Joint Open 4:9, pages 704-712.
Crossref
John P. A. Ioannidis, Francesco Zonta & Michael Levitt. (2023) What Really Happened During the Massive SARS-CoV-2 Omicron Wave in China?. JAMA Internal Medicine 183:7, pages 633.
Crossref
Emily J. Doucette, Joslyn Gray, Kevin Fonseca, Carmen Charlton, Jamil N. Kanji, Graham Tipples, Susan Kuhn, Jessica Dunn, Payton Sayers, Nicola Symonds, Guosong Wu, Stephen B. Freedman & James D. Kellner. (2023) A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study. PLOS ONE 18:4, pages e0284046.
Crossref
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J Cowling, Gabriel M Leung & Dennis Kai Ming Ip. (2023) Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. The Lancet Infectious Diseases 23:4, pages 421-434.
Crossref
Maja Socan, Katarina Prosenc & Maja Mrzel. (2023) Seroprevalence of Anti-SARS-CoV-2 Antibodies Following the Omicron BA.1 Wave. International Journal of Environmental Research and Public Health 20:4, pages 3665.
Crossref
Kelly M. O’Shea, Charles F. SchulerIVIV, Jesse Chen, Jonathan P. Troost, Pamela T. Wong, Kelsea Chen, Daniel R. O’Shea, Westley Peng, Carmen Gherasim, David M. Manthei, Riccardo Valdez, James L. Baldwin & James R. BakerJr.Jr.. (2023) Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing. Frontiers in Immunology 14.
Crossref
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, Cheuk Kwong Lee, Asmaa Hachim, Leo C. H. Tsang, Kenny W. H. Yam, Sara Chaothai, Kelvin K. H. Kwan, Zacary Y. H. Chai, Tiffany H. K. Lo, Masashi Mori, Chao Wu, Sophie A. Valkenburg, Gaya K. Amarasinghe, Eric H. Y. Lau, David S. C. Hui, Gabriel M. Leung, Malik Peiris & Joseph T. Wu. (2023) Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nature Medicine 29:2, pages 348-357.
Crossref
Shuk-Ching Wong, Albert Ka-Wing Au, Janice Yee-Chi Lo, Pak-Leung Ho, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Kwok-Yung Yuen & Vincent Chi-Chung Cheng. (2022) Evolution and Control of COVID-19 Epidemic in Hong Kong. Viruses 14:11, pages 2519.
Crossref
Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Chantale Pambrun & Steven J. Drews. (2022) SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron. Viruses 14:11, pages 2336.
Crossref